Beit Jala Pharmaceutical Company announced unaudited earnings results for the full year ended December 31, 2018. For the period, the company reported sales of JOD 7,036,939 against JOD 8,323,963 a year ago. Net Income after tax was JOD 769,649 or JOD 0.110 per basic and diluted share against JOD 1,645,697 or JOD 0.235 per basic and diluted share a year ago.